1. G. Mariani, S. Vidal-Sicart, R.A. Valdes Olmos (Eds): Atlas of Lymphoscintigraphy and Sentinel Node Mapping, Second Edition

   • Marilena Sicignano
   • Luigi Mansi

   Book Review 03 June 2021 Pages: 3345 - 3346

2. Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma

   • Wei Qin
   • Xufeng Jiang
   • Weili Zhao

   Letter to the Editor 23 March 2021 Pages: 3347 - 3350

   

3. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?

   • Romain-David Seban
   • Laurence Champion
   • Laurent Dercle

   Letter to the Editor 23 June 2021 Pages: 3351 - 3352

4. Radiomics analysis of [¹⁸F] FDG PET/CT for microvascular invasion and prognosis prediction in very-early and early-stage hepatocellular carcinoma

   • Wenfei Li
   • Tahir Mehmood Shakir
   • Zhanqiu Wang

   Letter to the Editor 24 June 2021 Pages: 3353 - 3354

5. Thyroid dysfunctions induced by molecular cancer therapies: a synopsis for nuclear medicine thyroidologists

   • Petra Petranović Ovčariček
   • Desiree Deandreis
   • Luca Giovanella

   Editorial 10 May 2021 Pages: 3355 - 3360

   

6. Impact of the COVID-19 pandemic on nuclear medicine departments in Europe

   • Ana Paula Moreira
   • François Jamar
   • Jolanta Kunikowska

   Editorial 30 July 2021 Pages: 3361 - 3364

7. EANM position paper on the role of radiobiology in nuclear medicine

   • An Aerts
   • Uta Eberlein
   • Michael Lassmann

   Original Article Open access 29 April 2021 Pages: 3365 - 3377

   

8. Image quality and lesion detectability in low-dose pediatric ¹⁸F-FDG scans using total-body PET/CT

   • Yu-Mo Zhao
   • Ying-He Li
   • Ying-Ying Hu

   Original Article 18 March 2021 Pages: 3378 - 3385

   

9. [¹⁸F]-C-SNAT4: an improved caspase-3-sensitive nanoaggregation PET tracer for imaging of tumor responses to chemo- and immunotherapies

   • Min Chen
   • Zixin Chen
   • Jianghong Rao

   Original Article 13 March 2021 Pages: 3386 - 3399

   

10. High-resolution radioluminescence microscopy of FDG uptake in an engineered 3D tumor-stoma model

    • Syamantak Khan
    • Sungwoo Kim
    • Guillem Pratx

    Original Article 21 April 2021 Pages: 3400 - 3407

    

11. Preclinical evaluation of [²²⁵Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms

    • Narges K. Tafreshi
    • Darpan N. Pandya
    • David L. Morse

    Original Article 26 March 2021 Pages: 3408 - 3421

    

12. Segmentation of white matter hyperintensities on ¹⁸F-FDG PET/CT images with a generative adversarial network

    • Kyeong Taek Oh
    • Dongwoo Kim
    • Sun Kook Yoo

    Original Article 11 March 2021 Pages: 3422 - 3431

    

13. [¹⁸F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation

    • Marta Ferreira
    • Pierre Lovinfosse
    • Roland Hustinx

    Original Article Open access 26 March 2021 Pages: 3432 - 3443

    

14. Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting

    • Andrei Iantsen
    • Marta Ferreira
    • Mathieu Hatt

    Original Article Open access 27 March 2021 Pages: 3444 - 3456

    

15. A novel deep-learning–based approach for automatic reorientation of 3D cardiac SPECT images

    • Duo Zhang
    • P. Hendrik Pretorius
    • Wentao Zhu

    Original Article 02 April 2021 Pages: 3457 - 3468

    

16. Multivariate radiomics models based on ¹⁸F-FDG hybrid PET/MRI for distinguishing between Parkinson’s disease and multiple system atrophy

    • Xuehan Hu
    • Xun Sun
    • Xiaoli Lan

    Original Article 07 April 2021 Pages: 3469 - 3481

    

17. Real-time intraoperative glioma diagnosis using fluorescence imaging and deep convolutional neural networks

    • Biluo Shen
    • Zhe Zhang
    • Jie Tian

    Original Article Open access 27 April 2021 Pages: 3482 - 3492

    

18. Value of [⁶⁸Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis

    • Yue Zhou
    • Xin Yang
    • Yue Chen

    Original Article 07 April 2021 Pages: 3493 - 3501

    

19. Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction

    • Alessia Gimelli
    • Alberto Aimo
    • Leslee J. Shaw

    Original Article 18 March 2021 Pages: 3502 - 3511

    

20. Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial

    • Federico Caobelli
    • Philip Haaf
    • on behalf of the BARDOT Investigators

    Original Article Open access 21 April 2021 Pages: 3512 - 3521

    

21. Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism

    • Katharina A. Schindlbeck
    • Deepak K. Gupta
    • David Eidelberg

    Original Article 10 April 2021 Pages: 3522 - 3529

    

22. Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study

    • Tiago Reis Marques
    • Mattia Veronese
    • Oliver D. Howes

    Original Article Open access 06 April 2021 Pages: 3530 - 3539

    

23. Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy

    • Dan Cohen
    • Shir Hazut Krauthammer
    • Einat Even-Sapir

    Original Article 08 May 2021 Pages: 3540 - 3549

    

24. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials

    • Dominic Kaddu-Mulindwa
    • Bettina Altmann
    • Dirk Hellwig

    Original Article Open access 29 April 2021 Pages: 3550 - 3559

    

25. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer

    • Romain-David Seban
    • Roman Rouzier
    • Laurence Champion

    Original Article 27 March 2021 Pages: 3560 - 3570

    

26. Dosimetry and optimal scan time of [¹⁸F]SiTATE-PET/CT in patients with neuroendocrine tumours

    • Leonie Beyer
    • Astrid Gosewisch
    • Harun Ilhan

    Original Article Open access 29 April 2021 Pages: 3571 - 3581

    

27. ¹⁷⁷Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life

    • Luohai Chen
    • Shaunak Navalkissoor
    • Aimee R. Hayes

    Original Article 09 April 2021 Pages: 3582 - 3594

    

28. Dose escalation study of targeted alpha therapy with [²²⁵Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy

    • Leszek Królicki
    • Frank Bruchertseifer
    • Alfred Morgenstern

    Original Article Open access 15 April 2021 Pages: 3595 - 3605

    

29. Clinical utility of [⁶⁸Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma

    • Liang Zhao
    • Yizhen Pang
    • Haojun Chen

    Original Article 01 April 2021 Pages: 3606 - 3617

    

30. A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer

    • Paula Demétrio de Souza França
    • Susanne Kossatz
    • Thomas Reiner

    Original Article 05 May 2021 Pages: 3618 - 3630

    

31. Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients

    • JM. González de Aledo-Castillo
    • S. Casanueva-Eliceiry
    • JA. Puig-Butillé

    Original Article 02 April 2021 Pages: 3631 - 3642

    

32. Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer

    • Margarita Kirienko
    • Martina Sollini
    • Arturo Chiti

    Original Article Open access 07 May 2021 Pages: 3643 - 3655

    

33. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation

    • Wenjie Miao
    • Pei Nie
    • Zhenguang Wang

    Original Article 04 April 2021 Pages: 3656 - 3665

    

34. Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan

    • Hayato Kaida
    • Kazuhiro Kitajima
    • Kazunari Ishii

    Original Article 02 May 2021 Pages: 3666 - 3682

    

35. Stereotactic radiotherapy to oligoprogressive lesions detected with ⁶⁸Ga-PSMA-PET/CT in castration-resistant prostate cancer patients

    • Cem Onal
    • Gokhan Ozyigit
    • Fadil Akyol

    Original Article 10 March 2021 Pages: 3683 - 3692

    

36. Can ⁶⁸Ga-PSMA-11 PET/CT predict pathological upgrading of prostate cancer from MRI-targeted biopsy to radical prostatectomy?

    • Haoli Yin
    • Mengxia Chen
    • Hongqian Guo

    Original Article 04 April 2021 Pages: 3693 - 3701

    

37. Detection of clinically significant prostate cancer with ¹⁸F-DCFPyL PET/multiparametric MR

    • Ur Metser
    • Claudia Ortega
    • Sangeet Ghai

    Original Article 12 April 2021 Pages: 3702 - 3711

    

38. Patterns of disease detection using [¹⁸F]DCFPyL PET/CT imaging in patients with detectable PSA post prostatectomy being considered for salvage radiotherapy: a prospective trial

    • Samantha Koschel
    • Kim Taubman
    • Michael Ng

    Original Article 14 April 2021 Pages: 3712 - 3722

    

39. Kinetic analysis and optimisation of ¹⁸F-rhPSMA-7.3 PET imaging of prostate cancer

    • Simona Malaspina
    • Vesa Oikonen
    • Mika Scheinin

    Original Article Open access 12 April 2021 Pages: 3723 - 3731

    

40. Simultaneous injection of ¹⁸F-BF3- Cy3-ACUPA and non-radioactive Cy7-ACUPA probes: a promising pre-biopsy PET and ex vivo fluorescence imaging approach to evaluate prostate cancer

    • Omer Aras
    • Cetin Demirdag
    • Haluk B Sayman

    Image of the Month 16 April 2021 Pages: 3732 - 3733

    

41. Diffuse cerebellar hypermetabolism: an early sign of leptomeningeal metastases

    • M. P. G. Broen
    • M. H. M. E. Anten
    • J. A. J. van der Pol

    Image of the Month Open access 17 April 2021 Pages: 3734 - 3735

    

42. ⁶⁸Ga-FAPI-46 and ¹⁸F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors

    • Masatoshi Hotta
    • Ida Sonni
    • Jeremie Calais

    Image of the Month 29 April 2021 Pages: 3736 - 3737

    

43. Ultra-short time imaging of total-body PET/CT for cancer pain-induced untenable body position

    • Yongjiang Li
    • Wenbiao Zhang
    • Wei Fan

    Image of the Month 08 May 2021 Pages: 3738 - 3740

    

44. Imaging superiority of [⁶⁸Ga]-FAPI-04 over [¹⁸F]-FDG PET/CT in alveolar soft part sarcoma (ASPS)

    • Xin Zhou
    • Shuailiang Wang
    • Nan Li

    Image of the Month 13 May 2021 Pages: 3741 - 3742

    

45. [⁶⁸Ga]Ga-DOTA-TATE uptake due to COVID-19 vaccination

    • Michal Weiler-Sagie
    • Elizabeth E. Half

    Image of the Month 22 May 2021 Pages: 3743 - 3744

    

46. Correction to: [¹⁸F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation

    • Marta Ferreira
    • Pierre Lovinfosse
    • Roland Hustinx

    Correction Open access 26 May 2021 Pages: 3745 - 3746